Outlook Therapeutics, Inc. — Form D

Outlook Therapeutics, Inc. of ISELIN, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2015-12-23. The offering totals $50.0M, of which $6.3M was reported sold. Industry: Other.

Offering

Issuer

Officers, directors & promoters (45)

Showing 25 of 45 people.

NameRoleLocation
Scott J CanuteDirectorCRANBURY, NJ
Donald J GriffithDirectorCRANBURY, NJ
Robin C HokeDirectorCRANBURY, NJ
Lawrence A KenyonDirectorIselin, NJ
Lawrence A KenyonExecutive OfficerIselin, NJ
Jeff A EvansonExecutive OfficerIselin, NJ
Faisal G SukhtianDirectorIselin, NJ
Julia A HallerDirectorIselin, NJ
Gerd G AuffarthDirectorIselin, NJ
Yezan H HaddadinDirectorIselin, NJ
Randy H ThurmanDirectorIselin, NJ
Julian G GangolliDirectorIselin, NJ
Andong G HuangDirectorIselin, NJ
Kurt J HilzingerDirectorIselin, NJ
Pankaj MohanDirectorPrinceton, NJ
Pankaj MohanExecutive OfficerPrinceton, NJ
Julian GangolliRelated PersonIselin, NJ
Jeff Russell EvansonExecutive OfficerIselin, NJ
C. Russell TrenaryDirectorIselin, NJ
C. Russell TrenaryExecutive OfficerIselin, NJ
Todd BradyDirectorAtlanta, GA
Randy ThurmanDirectorMonmouth Junction, NJ
Yezan HaddadinDirectorIselin, NJ
Yezan HaddadinRelated PersonIselin, NJ
Jeff G EvansonExecutive OfficerMonmouth Junction, NJ

Other filings by this issuer (12)

FiledFormOfferingSold
2026-05-07D$5.0M
2025-01-27D$32.0M
2024-04-16D$13.3M$5.0M
2024-03-29D$159.0M$60.0M
2023-01-06D$1.0M$1.0M
2023-01-06D$31.8M$31.8M
2021-02-12D$4.0M$4.0M
2020-06-09D$16.0M$16.0M
2020-03-11D$8.0M$8.0M
2017-09-25D$40.1M$3.3M
2015-10-13D$14.5M$14.5M
2015-08-10D$31.1M$31.1M

More